Blood Tests for Monitoring Polycythemia Vera
Essential Routine Monitoring Tests
- The American College of Physicians recommends that hematocrit must be maintained below 45% in all patients to reduce thrombotic risk, requiring frequent monitoring during phlebotomy therapy 1, 2
- A sustained increase of ≥2 g/dL hemoglobin from baseline warrants investigation even within normal reference ranges 2
- Low MCHC (<32%) suggests iron deficiency that can mask true erythrocytosis, requiring serum ferritin, iron studies, and transferrin saturation assessment 2
Specialized Monitoring Tests
- Low EPO levels have >90% specificity for PV and should be measured periodically, though normal EPO does not exclude PV (sensitivity <70%) 1, 2, 4
- EPO levels remain low even during phlebotomy treatment 4
- Bone marrow iron stores are typically decreased in PV and should be considered during diagnostic evaluation 3, 4
Additional Monitoring Considerations
- Elevated leukocyte alkaline phosphatase and increased serum vitamin B12 levels lack sensitivity and specificity but may be tracked 5
Critical Monitoring Pitfalls to Avoid
- Do not rely on hematocrit alone when MCHC is low, as iron deficiency can falsely normalize hematocrit while true erythrocytosis persists 2
- Dehydration is the most common cause of falsely elevated hematocrit and must be excluded before intensifying therapy 2
- Red cell mass (RCM) measurement is not routinely needed for monitoring, as normal RCM does not rule out PV and adds unnecessary cost 4, 5
- Traditional markers like splenomegaly presence alone lack sufficient sensitivity and specificity for monitoring disease activity 5